Tailoring Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Recent Advances and Strategies

JCO Oncol Pract. 2024 Mar 12:OP2300563. doi: 10.1200/OP.23.00563. Online ahead of print.

Authors

Francisco J Esteva^{1

2}, Elena Katz^{1

2}

Affiliations

¹ Northwell, New Hyde Park, NY.
² Northwell Health Cancer Institute, Lake Success, NY.

PMID: 38471052
DOI: 10.1200/OP.23.00563

Abstract

Neoadjuvant HER2 Therapy: Beyond one-size-fits-all.

Publication types

Review